Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 25 | 2024 | 493 | 6.650 |
Why?
|
Papillomavirus Infections | 28 | 2024 | 1640 | 5.600 |
Why?
|
Head and Neck Neoplasms | 27 | 2024 | 2930 | 5.160 |
Why?
|
Papillomaviridae | 15 | 2024 | 1140 | 2.500 |
Why?
|
Carcinoma, Squamous Cell | 19 | 2024 | 4050 | 2.480 |
Why?
|
Alphapapillomavirus | 4 | 2022 | 219 | 1.930 |
Why?
|
DNA, Viral | 11 | 2024 | 2201 | 1.370 |
Why?
|
Free Tissue Flaps | 3 | 2024 | 335 | 1.310 |
Why?
|
Salivary Gland Neoplasms | 4 | 2016 | 306 | 0.960 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2016 | 263 | 0.940 |
Why?
|
Receptor, Notch1 | 2 | 2018 | 518 | 0.870 |
Why?
|
Human papillomavirus 16 | 5 | 2023 | 268 | 0.800 |
Why?
|
Oncogene Proteins, Viral | 2 | 2023 | 342 | 0.780 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2022 | 102 | 0.760 |
Why?
|
Nasolacrimal Duct | 1 | 2022 | 79 | 0.740 |
Why?
|
Tonsillar Neoplasms | 1 | 2021 | 49 | 0.740 |
Why?
|
Sexual Behavior | 3 | 2018 | 2197 | 0.570 |
Why?
|
Electric Power Supplies | 1 | 2018 | 96 | 0.560 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1608 | 0.560 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 49 | 0.510 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 220 | 0.510 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9412 | 0.500 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 269 | 0.500 |
Why?
|
Scalp | 1 | 2018 | 391 | 0.480 |
Why?
|
Age Factors | 8 | 2021 | 18407 | 0.450 |
Why?
|
Mouth Neoplasms | 4 | 2024 | 597 | 0.450 |
Why?
|
Middle Ear Ventilation | 1 | 2014 | 101 | 0.430 |
Why?
|
Epidemics | 2 | 2018 | 517 | 0.430 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1141 | 0.430 |
Why?
|
Cochlear Implants | 1 | 2018 | 342 | 0.430 |
Why?
|
Mouth | 1 | 2015 | 383 | 0.420 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2429 | 0.390 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1144 | 0.390 |
Why?
|
Otitis Media | 1 | 2014 | 288 | 0.390 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.380 |
Why?
|
Neoplasm Staging | 8 | 2024 | 11221 | 0.370 |
Why?
|
Prognosis | 16 | 2024 | 29979 | 0.360 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1742 | 0.350 |
Why?
|
Middle Aged | 41 | 2024 | 223422 | 0.350 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1390 | 0.340 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1765 | 0.330 |
Why?
|
Carcinoma | 2 | 2018 | 2330 | 0.290 |
Why?
|
Aged | 31 | 2024 | 171446 | 0.280 |
Why?
|
Humans | 61 | 2024 | 767991 | 0.270 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3443 | 0.270 |
Why?
|
Male | 45 | 2024 | 364641 | 0.270 |
Why?
|
Smoking Cessation | 1 | 2018 | 2085 | 0.260 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59598 | 0.250 |
Why?
|
Retrospective Studies | 27 | 2024 | 81746 | 0.250 |
Why?
|
Female | 43 | 2024 | 397113 | 0.230 |
Why?
|
Cutaneous Fistula | 1 | 2014 | 79 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3837 | 0.220 |
Why?
|
Umbilicus | 1 | 2013 | 38 | 0.220 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2043 | 0.220 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.210 |
Why?
|
Fistula | 1 | 2014 | 213 | 0.210 |
Why?
|
Osteoradionecrosis | 1 | 2022 | 51 | 0.200 |
Why?
|
Laryngectomy | 1 | 2014 | 245 | 0.200 |
Why?
|
Maryland | 3 | 2018 | 278 | 0.190 |
Why?
|
Laparotomy | 1 | 2013 | 459 | 0.190 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2902 | 0.190 |
Why?
|
Laryngeal Diseases | 1 | 2014 | 248 | 0.190 |
Why?
|
Parathyroid Hormone | 2 | 2018 | 1804 | 0.190 |
Why?
|
Palatine Tonsil | 1 | 2021 | 193 | 0.180 |
Why?
|
Risk Factors | 13 | 2021 | 74936 | 0.180 |
Why?
|
Minnesota | 1 | 2020 | 339 | 0.170 |
Why?
|
DNA | 2 | 2023 | 7213 | 0.160 |
Why?
|
Cleavage And Polyadenylation Specificity Factor | 1 | 2008 | 16 | 0.160 |
Why?
|
RNA 3' End Processing | 1 | 2008 | 16 | 0.160 |
Why?
|
Pain Measurement | 2 | 2020 | 3583 | 0.150 |
Why?
|
Tongue | 1 | 2021 | 406 | 0.150 |
Why?
|
Baltimore | 1 | 2018 | 233 | 0.150 |
Why?
|
Cicatrix | 1 | 2013 | 798 | 0.140 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6843 | 0.140 |
Why?
|
Triage | 1 | 2024 | 996 | 0.140 |
Why?
|
Cohort Studies | 5 | 2024 | 41749 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2024 | 984 | 0.140 |
Why?
|
Otolaryngology | 1 | 2024 | 699 | 0.140 |
Why?
|
Mutation | 3 | 2018 | 30211 | 0.140 |
Why?
|
Parathyroidectomy | 1 | 2018 | 244 | 0.130 |
Why?
|
Incidence | 7 | 2018 | 21532 | 0.130 |
Why?
|
Parathyroid Glands | 1 | 2018 | 522 | 0.130 |
Why?
|
Qualitative Research | 2 | 2024 | 3140 | 0.130 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2018 | 164 | 0.130 |
Why?
|
Salvage Therapy | 2 | 2021 | 1273 | 0.130 |
Why?
|
Hypocalcemia | 1 | 2017 | 205 | 0.130 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2022 | 798 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7470 | 0.130 |
Why?
|
Endonucleases | 1 | 2008 | 371 | 0.130 |
Why?
|
Conserved Sequence | 1 | 2008 | 1162 | 0.120 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2015 | 91 | 0.120 |
Why?
|
Polymerase Chain Reaction | 1 | 2024 | 6071 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 467 | 0.120 |
Why?
|
Protein Subunits | 1 | 2008 | 943 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 275 | 0.120 |
Why?
|
Perimenopause | 1 | 2016 | 142 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26375 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1002 | 0.120 |
Why?
|
Calcium | 2 | 2018 | 5794 | 0.120 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 404 | 0.120 |
Why?
|
Otoscopy | 1 | 2014 | 40 | 0.120 |
Why?
|
Chloride Channels | 1 | 2015 | 221 | 0.120 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.110 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2017 | 290 | 0.110 |
Why?
|
Adult | 21 | 2024 | 223583 | 0.110 |
Why?
|
SEER Program | 2 | 2016 | 1444 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1738 | 0.110 |
Why?
|
Otitis Media with Effusion | 1 | 2014 | 115 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2017 | 514 | 0.110 |
Why?
|
Device Removal | 1 | 2018 | 643 | 0.100 |
Why?
|
Laryngoscopy | 1 | 2018 | 714 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2021 | 15831 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2016 | 12797 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2018 | 948 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1698 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39345 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2017 | 913 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6517 | 0.100 |
Why?
|
Disabled Persons | 1 | 2021 | 1210 | 0.090 |
Why?
|
Thyroid Gland | 1 | 2018 | 1172 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3619 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2016 | 751 | 0.090 |
Why?
|
Survival Analysis | 3 | 2018 | 10098 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 853 | 0.090 |
Why?
|
Counseling | 1 | 2018 | 1554 | 0.080 |
Why?
|
Epigenomics | 1 | 2015 | 959 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3231 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2014 | 570 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2506 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2510 | 0.080 |
Why?
|
Quality of Life | 2 | 2024 | 13489 | 0.080 |
Why?
|
Sex Factors | 5 | 2018 | 10627 | 0.080 |
Why?
|
Pilot Projects | 2 | 2021 | 8740 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 668 | 0.080 |
Why?
|
Histones | 1 | 2008 | 2600 | 0.070 |
Why?
|
United States | 6 | 2018 | 73027 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7851 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12536 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11068 | 0.070 |
Why?
|
Prevalence | 4 | 2018 | 15867 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2023 | 15442 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3618 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2022 | 22287 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13000 | 0.060 |
Why?
|
Recurrence | 2 | 2018 | 8507 | 0.060 |
Why?
|
Risk Assessment | 3 | 2018 | 24314 | 0.060 |
Why?
|
Prospective Studies | 2 | 2023 | 54924 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2381 | 0.060 |
Why?
|
DNA Methylation | 2 | 2016 | 4426 | 0.060 |
Why?
|
Survival Rate | 2 | 2019 | 12828 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 65364 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4785 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5861 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2953 | 0.060 |
Why?
|
Correspondence as Topic | 1 | 2024 | 34 | 0.060 |
Why?
|
Adolescent | 4 | 2023 | 89155 | 0.060 |
Why?
|
Signal Transduction | 2 | 2018 | 23642 | 0.060 |
Why?
|
Internship and Residency | 1 | 2024 | 5952 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7241 | 0.050 |
Why?
|
Disease Management | 1 | 2014 | 2533 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 79 | 0.050 |
Why?
|
Parotid Gland | 1 | 2022 | 178 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11873 | 0.040 |
Why?
|
Time Factors | 3 | 2018 | 40214 | 0.040 |
Why?
|
Tracheostomy | 1 | 2014 | 430 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9536 | 0.040 |
Why?
|
Organs at Risk | 1 | 2022 | 367 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20757 | 0.040 |
Why?
|
Suture Techniques | 1 | 2013 | 775 | 0.040 |
Why?
|
Hemoglobins | 1 | 2014 | 1531 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13665 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4748 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6809 | 0.040 |
Why?
|
Infant | 2 | 2014 | 36534 | 0.040 |
Why?
|
RNA Precursors | 1 | 2008 | 196 | 0.040 |
Why?
|
Child, Preschool | 2 | 2014 | 42665 | 0.030 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 110 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7445 | 0.030 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2018 | 145 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2741 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15944 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 930 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2014 | 1682 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2916 | 0.030 |
Why?
|
Salivary Glands | 1 | 2016 | 231 | 0.030 |
Why?
|
California | 1 | 2018 | 1438 | 0.030 |
Why?
|
Vocal Cords | 1 | 2018 | 520 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4904 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 706 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2022 | 1967 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2022 | 1679 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2008 | 3587 | 0.030 |
Why?
|
HeLa Cells | 1 | 2008 | 3074 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 60048 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1892 | 0.020 |
Why?
|
Child | 2 | 2014 | 80906 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3771 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3472 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2908 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2276 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3948 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1736 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2871 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3385 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2863 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 10590 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3628 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6339 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3476 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2783 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3609 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6495 | 0.020 |
Why?
|
Base Sequence | 1 | 2008 | 12418 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8535 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13420 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2982 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17617 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5798 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20218 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12075 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15597 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14718 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8082 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8637 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17128 | 0.010 |
Why?
|
Mice | 1 | 2016 | 82024 | 0.000 |
Why?
|
Animals | 1 | 2016 | 169222 | 0.000 |
Why?
|